vs
agilon health, inc.（AGL）与Rocket Companies, Inc.（RKT）财务数据对比。点击上方公司名可切换其他公司
Rocket Companies, Inc.的季度营收约是agilon health, inc.的1.7倍（$2.7B vs $1.6B），Rocket Companies, Inc.净利率更高（2.5% vs -12.0%，领先14.6%），Rocket Companies, Inc.同比增速更快（52.2% vs 3.1%），agilon health, inc.自由现金流更多（$-23.5M vs $-1.3B），过去两年Rocket Companies, Inc.的营收复合增速更高（39.5% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Rocket Companies, Inc.是美国金融科技及住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
AGL vs RKT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $2.7B |
| 净利润 | $-188.9M | $68.0M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | 6.3% |
| 净利率 | -12.0% | 2.5% |
| 营收同比 | 3.1% | 52.2% |
| 净利润同比 | -78.5% | 100.8% |
| 每股收益（稀释后） | — | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.6B | $2.7B | ||
| Q3 25 | $1.4B | $1.6B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.5B | $1.0B | ||
| Q4 24 | $1.5B | $1.8B | ||
| Q3 24 | $1.5B | $646.9M | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $-188.9M | $68.0M | ||
| Q3 25 | $-110.2M | $-123.9M | ||
| Q2 25 | $-104.4M | $-1.8M | ||
| Q1 25 | $12.1M | $-10.4M | ||
| Q4 24 | $-105.8M | $33.9M | ||
| Q3 24 | $-117.6M | $-22.0M | ||
| Q2 24 | $-30.7M | $1.3M | ||
| Q1 24 | $-6.1M | $16.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | -8.4% | ||
| Q2 24 | — | 47.4% | ||
| Q1 24 | — | 51.2% |
| Q4 25 | -12.3% | 6.3% | ||
| Q3 25 | -9.1% | -11.5% | ||
| Q2 25 | -8.3% | 1.8% | ||
| Q1 25 | -1.4% | -21.5% | ||
| Q4 24 | -7.1% | 38.1% | ||
| Q3 24 | -9.2% | -76.9% | ||
| Q2 24 | -2.9% | 14.8% | ||
| Q1 24 | -0.4% | 21.6% |
| Q4 25 | -12.0% | 2.5% | ||
| Q3 25 | -7.7% | -7.7% | ||
| Q2 25 | -7.5% | -0.1% | ||
| Q1 25 | 0.8% | -1.0% | ||
| Q4 24 | -6.9% | 1.9% | ||
| Q3 24 | -8.1% | -3.4% | ||
| Q2 24 | -2.1% | 0.1% | ||
| Q1 24 | -0.4% | 1.2% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $2.7B |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $22.9B |
| 总资产 | $1.3B | $60.7B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
| Q4 25 | $173.7M | $2.7B | ||
| Q3 25 | $171.7M | $5.8B | ||
| Q2 25 | $171.4M | $5.1B | ||
| Q1 25 | $136.9M | $1.4B | ||
| Q4 24 | $188.2M | $1.3B | ||
| Q3 24 | $148.2M | $1.2B | ||
| Q2 24 | $109.5M | $1.3B | ||
| Q1 24 | $111.7M | $861.4M |
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $126.7M | $22.9B | ||
| Q3 25 | $306.1M | $8.9B | ||
| Q2 25 | $408.9M | $7.4B | ||
| Q1 25 | $500.3M | $8.6B | ||
| Q4 24 | $471.0M | $9.0B | ||
| Q3 24 | $574.9M | $8.4B | ||
| Q2 24 | $676.6M | $8.8B | ||
| Q1 24 | $689.3M | $8.6B |
| Q4 25 | $1.3B | $60.7B | ||
| Q3 25 | $1.6B | $33.6B | ||
| Q2 25 | $1.7B | $30.4B | ||
| Q1 25 | $1.9B | $25.3B | ||
| Q4 24 | $1.7B | $24.5B | ||
| Q3 24 | $2.1B | $25.1B | ||
| Q2 24 | $2.2B | $23.6B | ||
| Q1 24 | $2.3B | $22.2B |
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $-1.3B |
| 自由现金流率自由现金流/营收 | -1.5% | -47.2% |
| 资本支出强度资本支出/营收 | 0.2% | 1.5% |
| 现金转化率经营现金流/净利润 | — | -18.08× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $-4.0B |
8季度趋势，按日历期对齐
| Q4 25 | $-20.5M | $-1.2B | ||
| Q3 25 | $-18.2M | $-50.3M | ||
| Q2 25 | $-35.1M | $-1.9B | ||
| Q1 25 | $-32.0M | $-797.0M | ||
| Q4 24 | $16.4M | $1.8B | ||
| Q3 24 | $-7.7M | $-1.3B | ||
| Q2 24 | $-18.7M | $-122.3M | ||
| Q1 24 | $-47.8M | $-3.0B |
| Q4 25 | $-23.5M | $-1.3B | ||
| Q3 25 | $-21.3M | $-71.8M | ||
| Q2 25 | $-38.3M | $-1.9B | ||
| Q1 25 | $-35.8M | $-811.0M | ||
| Q4 24 | $13.2M | $1.8B | ||
| Q3 24 | $-11.2M | $-1.4B | ||
| Q2 24 | $-22.0M | $-138.3M | ||
| Q1 24 | $-50.9M | $-3.0B |
| Q4 25 | -1.5% | -47.2% | ||
| Q3 25 | -1.5% | -4.5% | ||
| Q2 25 | -2.7% | -137.2% | ||
| Q1 25 | -2.3% | -78.2% | ||
| Q4 24 | 0.9% | 103.1% | ||
| Q3 24 | -0.8% | -209.6% | ||
| Q2 24 | -1.5% | -10.6% | ||
| Q1 24 | -3.2% | -218.7% |
| Q4 25 | 0.2% | 1.5% | ||
| Q3 25 | 0.2% | 1.3% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.3% | 1.4% | ||
| Q4 24 | 0.2% | 1.1% | ||
| Q3 24 | 0.2% | 2.9% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.2% | 1.0% |
| Q4 25 | — | -18.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.64× | — | ||
| Q4 24 | — | 54.42× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -94.46× | ||
| Q1 24 | — | -185.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |
